Watchful Waiting and Active Surveillance

What Is Watchful Waiting and Active Surveillance?

It is estimated that about one in nine men in the United States will be diagnosed with prostate cancer during their lifetime. When discussing prostate cancer management, you may hear the terms “watchful waiting” and “active surveillance.” Both approaches involve monitoring the cancer rather than starting treatment immediately, but they differ in their purpose and level of monitoring.

Watchful Waiting

Watchful waiting is a less intensive management strategy. It is often recommended for older men or individuals with other significant health conditions where the potential risks or side effects of prostate cancer treatment may outweigh the benefits.

With watchful waiting, the goal is to observe the cancer and address symptoms if they develop. This approach usually does not involve frequent or detailed testing. Instead, patients attend periodic check-ups with their doctor, and treatment is considered only if the cancer begins to cause symptoms that affect quality of life.

Active Surveillance

Active surveillance is a more structured and closely monitored approach. It is commonly recommended for men with low-risk, early-stage prostate cancer that is unlikely to grow or spread quickly.

The goal of active surveillance is to carefully track the cancer and begin treatment if there are signs that it is becoming more aggressive. This approach typically involves regular monitoring, including PSA blood tests, digital rectal exams (DRE), and sometimes prostate biopsies.

By closely observing the cancer, active surveillance allows patients to delay or avoid treatments such as surgery or radiation while still maintaining the opportunity for effective treatment if the cancer progresses.

Choosing the Right Approach

Both watchful waiting and active surveillance are based on the understanding that some prostate cancers grow very slowly and may not immediately threaten health. Because treatments for prostate cancer can carry potential side effects, monitoring strategies may be appropriate for certain patients.

The decision between watchful waiting and active surveillance depends on several factors, including your age, overall health, the stage and grade of the cancer, and your personal preferences. A thorough discussion with your doctor can help determine the most appropriate approach for your individual situation.